BioHealth News
Rockville Economic Development, Inc. (REDI) Announces BioBoost Series
Rockville Economic Development, Inc. (REDI) is set to launch its first BioBoost series on March 20, 2024, in Rockville, MD. This pioneering event, titled…
Read MoreBioBuzz’s 10 Women in the Life Sciences That You Should Know in the BioHealth Capital Region
In honor of Women’s History Month, which kicks off today, we wanted to highlight 10 incredible women making a mark in the life sciences…
Read MoreTEDCO Announces SSBCI Investment in Linshom Medical
Maryland company continues toward goal of supporting improved patient safety COLUMBIA, Md. (February 29, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced…
Read MoreGain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
BETHESDA, Md., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read MoreATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
MANASSAS, Va. & TEL AVIV, Israel--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, and Tissue Dynamics, a disruptive pharma-tech company integrating…
Read MoreThree Congressional Letters Show the March-In Debate Has Shifted
When the Biden Administration unleashed its proposed march-in guidelines last December, it claimed they would be a powerful tool for lowering drug prices by…
Read MoreHBR: How the Pandemic Rebooted Entrepreneurship in the U.S.
The Covid-19 pandemic triggered an unexpected boom in entrepreneurship, as Americans opted to start businesses at record rates. Just as unexpected has been the…
Read MoreEmpowering Change: Lance Kawaguchi’s Journey with the Cure Brain Cancer Foundation
Join us for an engaging episode of BioTalk as we sit down with Lance Kawaguchi, Chief Executive Officer of the Cure Brain Cancer Foundation.…
Read MoreBeyond the Breakthrough: Overcoming Georgetown’s spinout challenge
Being a university in Washington DC poses interesting challenges, but Georgetown University's Tatiana Litvin-Vechnyak is determined to turn them into opportunities. Weirdly, being located…
Read MoreGSK completes acquisition of Aiolos Bio
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing the…
Read MoreLab Space Available at Johns Hopkins Science & Technology Park
Attention life sciences companies seeking lab space in Baltimore: Starting June 1st, a fully built-out lab/office space will be available at the Science &…
Read MoreAstraZeneca Completes Acquisition of Gracell Biotechnologies
AstraZeneca today announced the successful completion of the acquisition of Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company developing innovative cell therapies for…
Read MoreLABIOTECH: Biotechs in the US Capital: seven key players based in Washington DC
Washington DC: The heart of the BioHealth Capital Region The BioHealth Capital Region (BHCR) encompasses Maryland, Virginia, and Washington D.C., and more than 1,800 life science…
Read MoreBIO comments on NIST proposal to use march-in rights for price controls
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process…
Read MoreBiden-Harris Administration’s ARPA-H commits $100 million to accelerate women’s health research
First Lady Jill Biden announces funding as first major deliverable from new White House Initiative on Women’s Health Research As the first major deliverable…
Read More